See the full article
Three regulatory warnings of serious adverse events slowed the growth
of use of atypical antipsychotic drugs among elderly patients with
dementia, but they did not reduce the overall prescription rate of
these drugs, found a research analysis of prescription drug claims data
in Ontario. The rate of use of these drugs actually increased 20% from
the month prior to the first warning in September 2002 to the end of
the study period in February 2007.
About 70% of people receiving antipsychotic drugs lived in nursing homes, and approximately 40% were aged 85 or older.
Three regulatory warnings of serious adverse events slowed the growth
of use of atypical antipsychotic drugs among elderly patients with
dementia, but they did not reduce the overall prescription rate of
these drugs, found a research analysis of prescription drug claims data
in Ontario. The rate of use of these drugs actually increased 20% from
the month prior to the first warning in September 2002 to the end of
the study period in February 2007.
About 70% of people receiving antipsychotic drugs lived in nursing homes, and approximately 40% were aged 85 or older.
No comments:
Post a Comment